CorMedix (CRMD) Other Non Operating Income (2011 - 2025)
CorMedix (CRMD) reported Other Non Operating Income of $75195.0 for Q4 2025, down 86.52% on a YoY basis from $557806.0 in Q4 2024, and up 203.39% sequentially from -$72727.0 in Q3 2025.
CorMedix (CRMD) Other Non Operating Income (2011 - 2025) Analysis & Trends
CorMedix (CRMD) has 12 years of Other Non Operating Income data on file, last reported at $75195.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 86.52% year-over-year to $75195.0; the trailing twelve-month figure through Dec 2025 stood at -$51999.0 (down 105.1% YoY), and the FY2025 full-year result was -$52000.0, down 110.02% from the prior year.
- Other Non Operating Income climbed to $75195.0 in Q4 2025, from -$72727.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $557806.0 in Q4 2024 to a low of -$72727.0 in Q3 2025.
- A 5-year average of $90377.2 and a median of -$1363.0 in 2021 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 45323.94% in 2024 and tumbled 852.4% in 2025, its largest moves.
- Tracing CRMD's Other Non Operating Income over 5 years: stood at -$9526.0 in 2021, then soared by 3302.27% to $305048.0 in 2022, then plunged by 99.6% to $1228.0 in 2023, then soared by 45323.94% to $557806.0 in 2024, then sank by 86.52% to $75195.0 in 2025.
- Business Quant data shows CRMD's Other Non Operating Income at $75195.0 in Q4 2025, -$72727.0 in Q3 2025, and -$16295.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75,195.00 |
| Sep 30, 2025 | -72,727.00 |
| Jun 30, 2025 | -16,295.00 |
| Mar 31, 2025 | -38,172.00 |
| Dec 31, 2024 | 557,806.00 |
| Sep 30, 2024 | -33,325.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | -4,008.00 |
| Dec 31, 2023 | 1,228.00 |
| Sep 30, 2023 | -29,199.00 |
| Jun 30, 2023 | 530,964.00 |
| Mar 31, 2023 | 12,345.00 |
| Dec 31, 2022 | 305,048.00 |
| Sep 30, 2022 | 23,572.00 |
| Jun 30, 2022 | 18,232.00 |
| Mar 31, 2022 | -1,833.00 |
| Dec 31, 2021 | -9,526.00 |
| Sep 30, 2021 | -4,447.00 |
| Jun 30, 2021 | -893.00 |
| Mar 31, 2021 | -6,420.00 |